Generic medicine company Zeno Health secures USD 25 million in funding led by STIC Investments to expand its footprint and enhance technology.
Mumbai, Feb 27 (PTI) Generic medicine-focused Zeno Health on Tuesday announced that it has received USD 25 million in funding in a round led by South Korea's STIC Investments.
Existing investor Lightbox was also a significant participant in the round and the funds will be deployed to expand footprint and enhance technological infrastructure, a statement said.
"The company remains steadfast in its mission to reach and serve 1 crore consumers monthly, aspiring to reduce their healthcare expenditure by 50 per cent," its chief executive and co-founder Siddharth Gadia said.
STIC's managing director Derrick (Kihyun) Yun said Zeno Health has demonstrated a remarkable commitment to reshaping the healthcare landscape in India and aligns with its values.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback